Capital International’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Capital International’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18,241	Closed	-$5.77M	–	160
2023 Q4	$5.77M	Buy	18,241 +8,014	+78%	+$1.56M	0.3%	91
2023 Q3	$1.73M	Buy	10,227 +10	+0.1%	+$1.88K	0.1%	141
2023 Q2	$2.22M	Buy	+10,217	New	+$2.19M	0.12%	134

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Capital International's KRTX Position: Q1 2024 in Review

Capital International sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 18,241 shares — an estimated $5.77M sold.

Capital International first reported a position in KRTX in Q2 2023 and held it in 3 quarters. The position peaked at $5.77M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Capital International reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Capital International sold 18,241 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $5.77M.
Capital International first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
Capital International's Karuna Therapeutics, Inc. Common Stock position peaked at $5.77M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Capital International's 13F filing for Q1 2024, filed 14 May 2024.